AbstractGlatiramer acetate (Copaxone®; GA) is a non-biological complex drug for multiple sclerosis. GA modulated thousands of genes in genome-wide expression studies conducted in THP-1 cells and mouse splenocytes. Comparing GA with differently-manufactured glatiramoid Polimunol (Synthon) in mice yielded hundreds of differentially expressed probesets, including biologically-relevant genes (e.g. Il18, adj p<9e−6) and pathways. In human monocytes, 700+ probesets differed between Polimunol and GA, enriching for 130+ pathways including response to lipopolysaccharide (adj. p<0.006). Key differences were confirmed by qRT-PCR (splenocytes) or proteomics (THP-1). These studies demonstrate the complexity of GA's mechanisms of action, and may help inf...
Glatiramer acetate (GA; Copaxone) is an approved drug for the treatment of multiple sclerosis (MS). ...
Glatopa™ is a generic glatiramer acetate recently approved for the treatment of patients with relaps...
Multiple sclerosis is a disease of the central nervous system, resulting in the demyelination of neu...
AbstractGlatiramer acetate (Copaxone®; GA) is a non-biological complex drug for multiple sclerosis. ...
Glatiramer acetate (GA) is a synthetic amino acid copolymer that is approved for treatment of relaps...
It is widely assumed that glatiramer acetate (GA), an approved agent for the immunomodulatory treatm...
Glatiramer acetate (GA; Copaxone), a disease-modifying therapy for multiple sclerosis (MS), promotes...
It is widely assumed that glatiramer acetate (GA), an approved agent for the immunomodulatory treatm...
Glatiramer acetate (GA, Copaxone((R))), a standardized mixture of synthetic polypeptides, has now be...
Glatiramer acetate (GA; Copaxone) is a random copolymer of glutamic acid, lysine, alanine, and tyros...
AbstractGlatiramer acetate (GA; Copaxone) is a random copolymer of glutamic acid, lysine, alanine, a...
Glatiramer acetate (GA; Copaxone) is a copolymer therapeutic that is approved by the Food and Drug A...
Glatiramer acetate treatment negatively regulates type I interferon signaling Objective: Glatiramer ...
ObjectiveGlatiramer acetate (GA; Copaxone), a disease-modifying therapy for multiple sclerosis (MS),...
Glatopa™ is a generic glatiramer acetate recently approved for the treatment of patients with relaps...
Glatiramer acetate (GA; Copaxone) is an approved drug for the treatment of multiple sclerosis (MS). ...
Glatopa™ is a generic glatiramer acetate recently approved for the treatment of patients with relaps...
Multiple sclerosis is a disease of the central nervous system, resulting in the demyelination of neu...
AbstractGlatiramer acetate (Copaxone®; GA) is a non-biological complex drug for multiple sclerosis. ...
Glatiramer acetate (GA) is a synthetic amino acid copolymer that is approved for treatment of relaps...
It is widely assumed that glatiramer acetate (GA), an approved agent for the immunomodulatory treatm...
Glatiramer acetate (GA; Copaxone), a disease-modifying therapy for multiple sclerosis (MS), promotes...
It is widely assumed that glatiramer acetate (GA), an approved agent for the immunomodulatory treatm...
Glatiramer acetate (GA, Copaxone((R))), a standardized mixture of synthetic polypeptides, has now be...
Glatiramer acetate (GA; Copaxone) is a random copolymer of glutamic acid, lysine, alanine, and tyros...
AbstractGlatiramer acetate (GA; Copaxone) is a random copolymer of glutamic acid, lysine, alanine, a...
Glatiramer acetate (GA; Copaxone) is a copolymer therapeutic that is approved by the Food and Drug A...
Glatiramer acetate treatment negatively regulates type I interferon signaling Objective: Glatiramer ...
ObjectiveGlatiramer acetate (GA; Copaxone), a disease-modifying therapy for multiple sclerosis (MS),...
Glatopa™ is a generic glatiramer acetate recently approved for the treatment of patients with relaps...
Glatiramer acetate (GA; Copaxone) is an approved drug for the treatment of multiple sclerosis (MS). ...
Glatopa™ is a generic glatiramer acetate recently approved for the treatment of patients with relaps...
Multiple sclerosis is a disease of the central nervous system, resulting in the demyelination of neu...